Dominika Écsiová

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 5

Top Topics

Multiple Myeloma

Chronic Lymphocytic Leukemia

Prognostic Factors

Peripheral Blood

Top Venues

Cancer medicine

European journal of clinical investigation

This page only lists publications with an associated author ORCID identifier.

Publications

Pavel Vodárek, Dominika Écsiová, Vladimíra Řezáčová, Ondřej Souček, Martin Simkovic, Doris Vokurková, David Belada, Pavel Žák, Vítězslav Bryja
Complex evaluation of serum immunoglobulin levels in patients with chronic lymphocytic leukemia: Significant increase in IgA after first-line chemoimmunotherapy. Cancer medicine 13 (15) (2024)
Pavel Vodárek, Dominika Écsiová, Vladimíra Řezáčová, Ondřej Souček, Martin Simkovic, Doris Vokurková, David Belada, Pavel Žák, Vítězslav Bryja
Complex evaluation of serum immunoglobulin levels in patients with chronic lymphocytic leukemia: Significant increase in IgA after first-line chemoimmunotherapy. Cancer medicine 13 (15) (2024)
Pavel Vodárek, Dominika Écsiová, Vladimíra Řezáčová, Ondřej Souček, Martin Simkovic, Doris Vokurková, David Belada, Pavel Žák, Vítězslav Bryja
Complex evaluation of serum immunoglobulin levels in patients with chronic lymphocytic leukemia: Significant increase in IgA after first-line chemoimmunotherapy. Cancer medicine 13 (15) (2024)
Pavel Vodárek, Dominika Écsiová, Vladimíra Řezáčová, Ondřej Souček, Martin Simkovic, Doris Vokurková, David Belada, Pavel Žák, Vítězslav Bryja
A comprehensive assessment of lymphocyte subsets, their prognostic significance, and changes after first-line therapy administration in patients with chronic lymphocytic leukemia. Cancer medicine (2022)
Martin Simkovic, Pavel Vodárek, Monika Motyčková, Dominika Écsiová, Petra Rozsívalová, Heidi Móciková, Pavla Štěpánková, Alice Sýkorová, Kateřina Hrochová, Filip Vrbacký, David Belada, Pavel Žák, Vítězslav Bryja
Rituximab, Cyclophosphamide and Dexamethasone (RCD) Chemoimmunotherapy for Relapsed Chronic Lymphocytic Leukaemia. European journal of clinical investigation 51 (4) (2020)